We're here to help.
    |

    Monday-Friday, 8 AM-8 PM EST

    Enroll Now

    connection patients to their treatment

    Affordability

    Connecting patients to their treatment

    NuvationConnect™ can help identify financial assistance options that may be available to your patients

    Select a program to see more information

    Bridge Program

    For patients whose coverage changes during treatment, NuvationConnect™ can provide a 30-day supply of medication to allow continuation of treatment while the new coverage is being established.

    • Existing patients only
    • Prescribed IBTROZI™
    • Commercial, Medicaid, Medicare, and cash-paying patients may be eligible
    • No income requirement

    Other terms and conditions apply.

    Enroll your patient in the Bridge Program

    Questions? We're here to help. Call 1-877-NUV-CON1 (1-877-688-2661) Monday-Friday, 8 AM-8 PM EST

    Questions? We're here to help. Call 1-877-NUV-CON1 (1-877-688-2661)

    Questions? We're here to help.

    1-877-NUV-CON1 (1-877-688-2661)

    Monday-Friday, 8 AM-8 PM EST

    nuvation connect logo
    Privacy NoticeTerms of Use

    NuvationConnect, the Nuvation Bio logo, and IBTROZI™ are registered trademarks of Nuvation Bio Inc. All company, product, and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.

    NuvationConnect™ services are available to residents of the United States only. This website is intended for residents and healthcare professionals of the United States only. NuvationConnect™ is not insurance, nor does it guarantee any product coverage or reimbursement outcome. The information in this site is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.

    © 2025 Nuvation Bio Inc. All rights reserved. MAT-IBT-0032 MAT-IBT-0038 06/2025